GlassScriptPhysician profile
Syed Amir Rizvi
NPI 1861494221
$14,962.34
in general payments reported to CMS, 2019-2025
43 companies · $3,404 in 2025
The $3,404 reported for 2025 was more than what 84% of Pulmonary Disease providers received nationally (typical 2025 total: $500).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $735 · 2020: $763 · 2021: $1,153 · 2022: $1,088 · 2023: $6,067 · 2024: $1,753 · 2025: $3,404.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $9,834 · Travel and Lodging: $1,299 · Education: $89.99.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $9,833.93 |
| Travel and Lodging | $1,299.35 |
| Education | $89.99 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Pinnacle Biologics, INC | $4,276.30 | 2023 | Photofrin |
| Astrazeneca Pharmaceuticals LP | $1,659.61 | 2019-2025 | Airsupra, Fasenra, Tezspire |
| Inspire Medical Systems, INC. | $1,553.36 | 2023-2025 | Inspire |
| Glaxosmithkline, LLC. | $1,495.04 | 2019-2025 | Nucala, Trelegy Ellipta, Arexvy |
| Mylan Specialty L.P. | $623.77 | 2019-2024 | Yupelri |
| Insmed, INC. | $584.33 | 2020-2025 | Arikayce, Brinsupri |
| Regeneron Healthcare Solutions, INC. | $530.07 | 2021-2025 | Dupixent |
| Boehringer Ingelheim Pharmaceuticals, INC. | $504.74 | 2019-2025 | Ofev, Stiolto Respimat, Jascayd |
| Harmony Biosciences LLC | $363.04 | 2020-2024 | Wakix |
| Philips North America LLC | $337.35 | 2020-2025 | Vest Therapy Und, Home Pi Undivided |
| Genzyme Corporation | $324.48 | 2023-2025 | |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $253.62 | 2023-2025 | Lifevest |
| Avadel Cns Pharmaceuticals, LLC | $252.41 | 2023-2025 | Lumryz |
| Electromed, INC. | $250.47 | 2019-2025 | Smartvest |
| Baxter Healthcare | $229.47 | 2023-2025 | Hillrom - Vest System Model 105 Home Care, Hillrom - Life 2000 Ventilation System |
Show all 43 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Inogen, INC. | $226.51 | 2022-2025 | Inogen One G5 Oxygen Concentrator - Bluetooth |
| Takeda Pharmaceuticals U.S.A., INC. | $154.47 | 2020-2025 | Glassia |
| Sunovion Pharmaceuticals INC. | $139.04 | 2019-2020 | |
| Jazz Pharmaceuticals INC. | $137.88 | 2020-2024 | |
| Grifols USA, LLC | $118.71 | 2019-2025 | Prolastin-C Liquid |
| Genentech USA, INC. | $103.35 | 2019-2025 | Ocrevus |
| Verona Pharma, INC. | $87.34 | 2025 | Ohtuvayre |
| Advanced Respiratory, INC | $77.30 | 2020-2021 | |
| Axsome Therapeutics, INC. | $62.34 | 2024-2025 | Sunosi |
| Viatris Specialty LLC | $61.55 | 2025 | Yupelri |
| Teva Pharmaceuticals USA, INC. | $55.67 | 2021 | |
| Merck Sharp & Dohme LLC | $55.63 | 2023-2024 | Keytruda |
| Mallinckrodt Hospital Products INC. | $48.28 | 2020 | |
| Mallinckrodt Enterprises LLC | $47.20 | 2019 | |
| Novartis Pharmaceuticals Corporation | $44.33 | 2023-2024 | |
| Fisher & Paykel Healthcare INC | $41.80 | 2022 | |
| Paratek Pharmaceuticals, INC. | $39.32 | 2023 | Nuzyra |
| Allergan, INC. | $38.92 | 2019 | |
| Vapotherm INC | $23.61 | 2021 | |
| Actelion Pharmaceuticals US, INC. | $23.47 | 2024 | Uptravi, Opsumit |
| Ani Pharmaceuticals, INC. | $22.58 | 2024 | Purified Cortrophin Gel |
| Optinose US, INC. | $20.63 | 2024 | |
| Abbvie INC. | $17.86 | 2022 | |
| Gilead Sciences, INC. | $16.60 | 2024 | Veklury |
| Cook Medical LLC | $16.51 | 2023 | Advance |
| Amgen INC. | $16.45 | 2023 | Tezspire |
| Circassia INC. | $15.44 | 2019 | |
| Chiesi USA, INC. | $11.49 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Syed Rizvi listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.